Lieber, S. B., Stamm, B. C., Young, S. R., Rose-Smith, J., Kleinman, J., Smole, A., Vega, J., Siegel, C. H., Barbhaiya, M., Mandl, L. A., Lockshin, M. D., & Sammaritano, L. R. (2025). Infant feeding experiences of women with systemic lupus erythematosus: A qualitative study. Lupus. https://doi.org/10.1177/09612033251324493

Zisa, D., Zhang-Sun, J., Christos, P. J., & Kirou, K. A. (2024). Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares. Lupus, 33(9), 938–947. https://doi.org/10.1177/09612033241260283

Kamen, D. L., Birt, J. A., Hadi, M. A., Gibbons, E., Bushnell, D. M., Yu, R., Delbecque, L. A., Griffing, K., & Askanase, A. (2022). Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey. Lupus, 32(3), 342–351. https://doi.org/10.1177/09612033221147479

Loiseau, P., Foret, T., DeFilippis, E. M., Risse, J., Etienne, A. D., Dufrost, V., Moulinet, T., Erkan, D., Devilliers, H., Wahl, D., & Zuily, S. (2022). Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Lupus, 31(13), 1595–1605. https://doi.org/10.1177/09612033221126852